611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO, CA
Other Events
Amended material disclosure
Annual Report to Security Holders
Appointment of June Bray to Quince Therapeutics Board of Directors
Reverse Stock Split Approved by Quince Therapeutics Board
Ex-99.1
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Q1
FY 2025
Notice of Late Filing for Annual Report
Q3
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence